- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 401/10 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Patent holdings for IPC class C07D 401/10
Total number of patents in this class: 2813
10-year publication summary
|
209
|
216
|
214
|
224
|
217
|
169
|
149
|
143
|
138
|
112
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4826 |
89 |
| Merck Patent GmbH | 5752 |
68 |
| LG Chem, Ltd. | 17706 |
60 |
| Takeda Pharmaceutical Company Limited | 2721 |
56 |
| Novartis AG | 10612 |
53 |
| Merck Sharp & Dohme LLC | 3732 |
49 |
| Samsung Display Co., Ltd. | 36317 |
44 |
| F. Hoffmann-La Roche AG | 7937 |
37 |
| Boehringer Ingelheim International GmbH | 4636 |
35 |
| Gilead Sciences, Inc. | 2106 |
35 |
| Tosoh Corporation | 1340 |
35 |
| Janssen Pharmaceutica N.V. | 3358 |
32 |
| VALO Health, Inc. | 176 |
32 |
| Hodogaya Chemical Co., Ltd. | 434 |
29 |
| Hoffmann-La Roche Inc. | 3546 |
25 |
| KalVista Pharmaceuticals Limited | 113 |
25 |
| Idemitsu Kosan Co., Ltd. | 4223 |
24 |
| Abbvie Inc. | 1817 |
24 |
| Novaled GmbH | 455 |
24 |
| Taisho Pharmaceutical Co., Ltd. | 869 |
22 |
| Other owners | 2015 |